CONNIE DU: Open Payments
NPI 1619459435 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,248 in 69 payments from 20 companies in 2025. Trend: 2023 $1,505 · 2024 $1,919 · 2025 $1,248
Food & beverage: $1,248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $217 |
| Novo Nordisk Inc | 13 | $203 |
| AstraZeneca Pharmaceuticals LP | 7 | $184 |
| GlaxoSmithKline, LLC. | 6 | $113 |
| Esperion Therapeutics, Inc. | 4 | $74 |
| Amgen Inc. | 4 | $67 |
| Corcept Therapeutics | 3 | $67 |
| PFIZER INC. | 3 | $63 |
| Astellas Pharma US Inc | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
Products named: Ozempic, TRELEGY ELLIPTA, BREZTRI, UBRELVY, NEXLETOL, QULIPTA, Korlym, VRAYLAR.
Industry payments across TN — which companies pay providers there.
